Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rifaximin on intestinally‐related pathologic changes in sickle cell disease
Dibyendu Dutta, Kelvin Li, Barbara A. Methé, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 4
Open Access | Times Cited: 15

Showing 15 citing articles:

Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events
Tim Jang, Maria Poplawska, Emanuela Cimpeanu, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions
Dibyendu Dutta, Seah H. Lim
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Neutrophils in sickle cell disease: Exploring their potential role as a therapeutic target
Lydian A. de Ligt, Aafke E. Gaartman, Bart J. Biemond, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 6, pp. 1119-1128
Open Access | Times Cited: 4
L-glutamine for sickle cell disease: more than reducing redox
Firas Jafri, Gyuhee Seong, Tim Jang, et al.
Annals of Hematology (2022) Vol. 101, Iss. 8, pp. 1645-1654
Closed Access | Times Cited: 16
Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis
Caitlin Lewis, Hassan Sellak, Mariem A. Sawan, et al.
FASEB BioAdvances (2023) Vol. 5, Iss. 5, pp. 199-210
Open Access | Times Cited: 7
Antimicrobial therapy during cancer treatment: Beyond antibacterial effects
Sassine Ghanem, Chang‐Jin Kim, Dibyendu Dutta, et al.
Journal of Internal Medicine (2020) Vol. 290, Iss. 1, pp. 40-56
Open Access | Times Cited: 19
Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice
Maroun Bou Zerdan, Stephanie Niforatos, Sandy Nasr, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 691-691
Open Access | Times Cited: 12
Endari treatment ameliorates sickle cell-related disruption in intestinal barrier functions and is associated with prolonged survival in sickle cell mice
Elio Haroun, Seah H. Lim, Dibyendu Dutta
Hematology (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Intestinal pathophysiological abnormalities in steady state and after vaso‐occlusive crisis in murine sickle cell disease
Maria Poplawska, Dibyendu Dutta, Manjunath Jayaram, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 3, pp. 777-780
Open Access | Times Cited: 11
Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease
Maria Poplawska, Dibyendu Dutta, Manjunath Jayaram, et al.
Annals of Hematology (2022) Vol. 101, Iss. 5, pp. 1009-1013
Closed Access | Times Cited: 6
Gut microbiota dysbiosis alters chronic pain behaviors in a humanized transgenic mouse model of sickle cell disease
Yavnika Kashyap, Zaijie Jim Wang
Pain (2023)
Closed Access | Times Cited: 2
Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell disease
Seah H. Lim, Dibyendu Dutta
American Journal of Hematology (2020) Vol. 95, Iss. 6
Open Access | Times Cited: 4
Antibiotics to modify sickle cell disease vaso-occlusive crisis?
Connor Stewart, Tim Jang, George Mo, et al.
Blood Reviews (2021) Vol. 50, pp. 100867-100867
Closed Access | Times Cited: 4
The Application of Rifaximin in Patients with End Stage Liver Disease
皓月 田
Advances in Clinical Medicine (2024) Vol. 14, Iss. 01, pp. 466-475
Closed Access
Implicaciones del microbioma en la etiología y el tratamiento del cáncer de próstata en humanos.
Miguel Tapia‐Rodríguez, Lina Paola Flores-Martínez, Isaac González‐Santoyo, et al.
Revista del Centro de Investigación de la Universidad la Salle (2021) Vol. 14, Iss. 56, pp. 87-112
Open Access | Times Cited: 1
Page 1

Scroll to top